Reversible leucoencephalopathy related to cyclosporin treatment;Leucoencefalopatia reversible relacionada con el tratamiento con ciclosporina

Revista de Neurologia

Volumn 25, Issue 139, 1997, Pages 471-473

  Grive E ^a,b   Rovira Canellas A ^a   Acebedo, G ^a   Alvarez Sabin J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Hospitals de la Vail d'Hebron   (Spain)

Author keywords

cerebral oedema; cyclosporin; hypertension; magnetic resonance

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN EDEMA; CASE REPORT; CLINICAL FEATURE; FEMALE; GRAFT REJECTION; HUMAN; HYPERTENSION; IMAGING; INTRAVENOUS DRUG ADMINISTRATION; LEUKOENCEPHALOPATHY; NEUROTOXICITY; AUTOTRANSPLANTATION; BONE TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; BONE MARROW TRANSPLANTATION; BONE TRANSPLANTATION; BRAIN EDEMA; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MYELODYSPLASTIC SYNDROMES; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030615173     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Nussbaum ES, Maxwell RE, Bitterman PB, et al. Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. J Neurosurg 1995; 82: 1068-1070.
2. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494-500.
3. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neuro-toxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR 1995; 165: 627-631.
4. Jansen O, Krieger D, Krieger S. Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy. AJNR 1996; 17: 337-344.
5. Truwit CL, Denaro CP, Lake JR, et al. MRI of reversible cyclosporin A induced neurotoxicity. AJNR 1991; 12: 651-659.
6. Pace MT, Slovis TL, Kelly JK, et al. Cyclosporin A toxicity: MRI appearance of the brain. Pediatr Radiol 1995; 25: 180-183.